Cite
HARVARD Citation
Yamaguchi, K. et al. (n.d.). 2120 Quality of life analysis in patients with RAS wild-type metastatic colorectal cancer treated with first-line FOLFIRI + cetuximab in the CRYSTAL study. European journal of cancer. pp. S370-S371. [Online].